As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Alopecia Market: By Disease Type: Androgenic Alopecia, Alopecia Areata, Ciatricial Alopecia, Traction Alopecia, Alopecia Totalis; By Drug Type; By Route of Administration; By Gender; By Distributional Channel; Regional Analysis; Historical Market and Forecast (2017-2027); Competitive Landscape; Industry Events and Developments

Global Alopecia Market Outlook

The global alopecia market size was estimated at USD 2.8 billion in 2020 and is anticipated to grow over the forecast period of 2022-2027 at a CAGR of 8.6%.

 

Global Alopecia Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

There are many different kinds of alopecia, each with a distinct cause. As is prevalent in male pattern baldness, alopecia can be located at the front and top of the head. It may be patchy as in an alopecia areata disorder. The alopecia market can be divided on the basis of segments like disease type, drug type, route of administration, gender, and distribution channel.

 

Global Alopecia Market By Drug Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The global alopecia market can be broadly categorised on the basis of disease type into:

  • Androgenic Alopecia
  • Alopecia Areata
  • Ciatricial Alopecia
  • Traction Alopecia
  • Alopecia Totalis

The industry can be divided on the basis of drug type as:

  • Minoxidil
  • Finasteride
  • Others

The global alopecia market can be categorised based on route of administration as:

  • Oral
  • Topical
  • Injectable

The industry can be divided based on gender as:

  • Males
  • Females

The global alopecia market can be divided on the basis of the distribution channel as:

  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies

The EMR report looks into the regional markets of alopecia like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Alopecia Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Alopecia Market Analysis

It is expected that the occurrence of Polycystic Ovary Syndrome (PCOS), cancer, hyperthyroidism, hypothyroidism, hypopituitarism, acute stress disorder, lupus, and other chronic illnesses will drive the global alopecia market. Changes in lifestyle such as frequent consumption of alcohol, tobacco, and related goods and increased concentrations of stress are regarded as powerful triggers for alopecia. While the precise causative factors stay unknown, genetic factors are associated with several instances. Increasing disposable earnings and increasing emphasis on aesthetic appearances are anticipated to contribute to the demand for therapy of alopecia. Hormonal imbalance and ageing accelerate the growth of hair loss instances, further aiding the global alopecia market growth. The overall increase in the geriatric population and rising customer consciousness of therapy alternatives are also anticipated to have a positive impact on the global alopecia market in the following years. During the forecast period, the product development of new therapeutic alternatives is anticipated to drive the industry growth. Other factors driving the industry include the introduction of fast-acting JAK inhibitors, the development of techniques to boost hair growth using human pluripotent stem cells, and PRP therapy.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global alopecia market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Cipla, Inc.
  • Sun Pharmaceuticals Industries Ltd.
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc
  • Lexington Intl., LLC
  • Cirrus Hair Centers
  • Transitions Hair
  • Follica, Inc.
  • Capillus
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Disease Type, Drug Type, Route of Administration, Gender, Distributional Channel, Region
Breakup by Disease Type Androgenic Alopecia, Alopecia Areata, Ciatricial Alopecia, Traction Alopecia, Alopecia Totalis
Breakup by Drug Type Minoxidil, Finasteride, Others
Breakup by Route of Administration Oral, Topical, Injectable
Breakup by Gender Males, Females
Breakup by Distribution Channel Hospitals, Retail Pharmacies, Online Pharmacies
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Cipla, Inc., Sun Pharmaceuticals Industries Ltd., Johnson & Johnson Services, Inc., Merck & Co., Inc, Lexington Intl., LLC, Cirrus Hair Centers, Transitions Hair, Follica, Inc., Capillus, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key findings of the Study
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Inference Data
3    Executive Summary
    3.1    Market Overview
    3.2    Market Analysis  
4    Global Alopecia Market Analysis
    4.1    Global Alopecia Historical Market (2017-2021) & Forecast (2022-2027)
    4.2    Global Alopecia Market Breakup by Disease Type
        4.2.1    Androgenic Alopecia
        4.2.2    Alopecia Areata
        4.2.3    Ciatricial Alopecia
        4.2.4    Traction Alopecia
        4.2.5    Alopecia Totalis
    4.3    Global Alopecia Market Breakup by Disease Type: Historical Market (2017-2021) & Forecast (2022-2027)
        4.3.1    Androgenic Alopecia
        4.3.2    Alopecia Areata
        4.3.3    Ciatricial Alopecia
        4.3.4    Traction Alopecia
        4.3.5    Alopecia Totalis
    4.4    Global Alopecia Market Breakup by Drug Type
        4.4.1    Minoxidil
        4.4.2    Finasteride
        4.4.3    Others
    4.5    Global Alopecia Market Breakup by Drug Type: Historical Market (2017-2021) & Forecast (2022-2027)
        4.5.1    Minoxidil
        4.5.2    Finasteride
        4.5.3    Others
    4.6    Global Alopecia Market Breakup by Route of Administration
        4.6.1    Oral
        4.6.2    Topical
        4.6.3    Injectable
    4.7    Global Alopecia Market Breakup by Route of Administration: Historical Market (2017-2021) & Forecast (2022-2027)
        4.7.1    Oral
        4.7.2    Topical
        4.7.3    Injectable 
    4.8    Global Alopecia Market Breakup by Gender
        4.8.1    Males
        4.8.2    Females
    4.9    Global Alopecia Market Breakup by Gender: Historical Market (2017-2021) & Forecast (2022-2027)
        4.9.1    Males
        4.9.2    Females
    4.10    Global Alopecia Market Breakup by Distributional Channel
        4.10.1    Hospitals
        4.10.2    Retail Pharmacies
        4.10.3    Online Pharmacies
    4.11    Global Alopecia Market Breakup by Distributional Channel: Historical Market (2017-2021) & Forecast (2022-2027)
        4.11.1    Hospitals
        4.11.2    Retail Pharmacies
        4.11.3    Online Pharmacies
    4.12    Global Alopecia Market Breakup by Region
         4.12.1    North America
            4.12.1.1    United States of America
            4.12.1.2    Canada
        4.12.2    Europe
            4.12.2.1    Germany
            4.12.2.2    United Kingdom
            4.12.2.3    France
            4.12.2.4    Italy
            4.12.2.5    Others
        4.12.3    Asia Pacific
            4.12.3.1    China
            4.12.3.2    Japan
            4.12.3.3    India
            4.12.3.4    ASEAN
            4.12.3.5    Others
        4.12.4    Latin America
            4.12.4.1    Brazil
            4.12.4.2    Argentina
            4.12.4.3    Mexico
            4.12.4.4    Others
        4.12.5    Middle East & Africa
            4.12.5.1    Saudi Arabia
            4.12.5.2    United Arab Emirates
            4.12.5.3    Nigeria
            4.12.5.4    South Africa
            4.12.5.5    Others
    4.13     Global Alopecia Market Breakup by Region: Historical Market (2017-2021) & Forecast (2022-2027)
         4.13.1    North America
            4.13.1.1    United States of America
            4.13.1.2    Canada
        4.13.2    Europe
            4.13.2.1    Germany
            4.13.2.2    United Kingdom
            4.13.2.3    France
            4.13.2.4    Italy
            4.13.2.5    Others
        4.13.3    Asia Pacific
            4.13.3.1    China
            4.13.3.2    Japan
            4.13.3.3    India
            4.13.3.4    ASEAN
            4.13.3.5    Others
        4.13.4    Latin America
            4.13.4.1    Brazil
            4.13.4.2    Argentina
            4.13.4.3    Mexico
            4.13.4.4    Others
        4.13.5    Middle East & Africa
            4.13.5.1    Saudi Arabia
            4.13.5.2    United Arab Emirates
            4.13.5.3    Nigeria
            4.13.5.4    South Africa
            4.13.5.5    Others
5    SWOT Analysis
    5.1    Overview
    5.2    Strengths
    5.3    Weaknesses
    5.4    Opportunities
    5.5    Threats
6    Porter’s Five Forces Analysis
    6.1    Overview
    6.2    Buyer’s Power
    6.3    Supplier’s Power
    6.4    New Entrants
    6.5    Degree of Rivalry
    6.6    Substitutes
7    Competitive Landscape & Supplier Analysis
    7.1    Cipla, Inc.
    7.2    Sun Pharmaceuticals Industries Ltd.
    7.3    Johnson & Johnson Services, Inc.
    7.4    Merck & Co., Inc
    7.5    Lexington Intl., LLC
    7.6    Cirrus Hair Centers
    7.7    Transitions Hair
    7.8    Follica, Inc.
    7.9    Capillus
    7.10    Others
8    Industry Events and Developments

Key Questions Answered in the Report

In 2020, the global alopecia market attained a value of nearly USD 2.8 billion.

The market is projected to grow at a CAGR of 8.6% between 2021 and 2026.

The major driver of the market includes the increasing occurrences of polycystic ovary syndrome, cancer, hyperthyroidism, hypothyroidism, hypopituitarism, acute stress disorder, lupus, and other chronic illnesses.

Changes in lifestyle such as frequent consumption of alcohol, tobacco, and related goods and increased concentrations of stress are the key industry trends propelling the growth of the market.

The major regions in the industry are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

The major disease types of alopecia in the market are androgenic alopecia, alopecia areata, ciatricial alopecia, traction alopecia, and alopecia totalis.

The significant drug types in the industry are minoxidil and finasteride, among others.

The leading routes of administration in the market are oral, topical, and injectable.

The major gender segments in the industry are males and females.

The significant distribution channels in the market are hospitals, retail pharmacies, and online pharmacies.

The major players in the industry are Cipla Inc., Sun Pharmaceuticals Industries Ltd., Johnson & Johnson Services Inc., Merck & Co. Inc., Lexington Intl. LLC, Cirrus Hair Centers, Transitions Hair, Follica Inc., and Capillus, among others.

Analyst Review

The global alopecia market attained a value of USD 2.8 billion in 2020, driven by the increasing occurrences of polycystic ovary syndrome, cancer, hyperthyroidism, hypothyroidism, hypopituitarism, acute stress disorder, lupus, and other chronic illnesses. Aided by the changes in lifestyle such as frequent consumption of alcohol, tobacco, and related goods, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 8.6%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on disease type, the alopecia industry can be segmented into androgenic alopecia, alopecia areata, ciatricial alopecia, traction alopecia, and alopecia totalis. On the basis of drug type, the market is divided into minoxidil, finasteride, and others. The industry can be segregated based on route of administration into oral, topical, and injectable. The market is bifurcated on the basis of gender into males and females. Based on distribution channel, the industry can be classified into hospitals, retail pharmacies, and online pharmacies. The major regional markets for alopecia are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific. The key players in the above market include Cipla Inc., Sun Pharmaceuticals Industries Ltd., Johnson & Johnson Services Inc., Merck & Co. Inc., Lexington Intl. LLC, Cirrus Hair Centers, Transitions Hair, Follica Inc., Capillus, and others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER